Literature DB >> 19816703

Ocular pharmacokinetic study on baicalin in lens of rabbits following intragastric administration.

Jia Zhiyan1, Bai Zhengzhong, Jiang Liange, Zhang Shujie, Duo Kai, Cui Hao, Yu Yongbin, Liu Ping.   

Abstract

PURPOSE: This paper is to study the pharmacokinetic features of baicalin in lens through observing baicalin's concentration changes in lens of rabbits following intragastric administration.
METHODS: Forty-four rabbits were randomly divided into 11 groups. The lens were collected at the beginning without any intragastric administration, and then collected after 15 minutes following intragastric administration of 80 mg/kg baicalin, and continually collected individually after 0.5,0.75,1,1.5,2,3,5,8,12 hours: the concentration of baicalin was measured by reversed-phase high-performance liquid chromatography (RP-HPLC).
RESULTS: There were two obvious peaks in the drug concentration-time diagram, appearing respectively at half an hour and 2 hours after the intragastric administration. The highest level of baicalin's concentration in lens (C( max ), = 4.997 microg/ml) was obtained 0.9 hour (T( max ) = 0.906 h) after application of baicalin. Area under the concentration time curve (AUC), half-life of the drug elimination (T( 1/2 )) and clearance ratio were 3.542 microg/ml*h., 1.576 h and 8.114 l/h respectively.
CONCLUSIONS: Baicalin can penetrate blood-eye barriers and enter the lens following intragastric administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816703     DOI: 10.1007/s00417-009-1206-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

Review 1.  Review: Oxidative stress and disease.

Authors:  A Spector
Journal:  J Ocul Pharmacol Ther       Date:  2000-04       Impact factor: 2.671

2.  Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin.

Authors:  D E Shieh; L T Liu; C C Lin
Journal:  Anticancer Res       Date:  2000 Sep-Oct       Impact factor: 2.480

3.  Investigation of the absorption mechanisms of baicalin and baicalein in rats.

Authors:  Liu Taiming; Jiang Xuehua
Journal:  J Pharm Sci       Date:  2006-06       Impact factor: 3.534

4.  [Pharmacological actions of baicalin and baicalein. 3. Action on experimental asthma].

Authors:  A Koda; H Nagai; Y Yoshida; H K Lauw
Journal:  Nihon Yakurigaku Zasshi       Date:  1970-09-20

5.  Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form.

Authors:  T Akao; K Kawabata; E Yanagisawa; K Ishihara; Y Mizuhara; Y Wakui; Y Sakashita; K Kobashi
Journal:  J Pharm Pharmacol       Date:  2000-12       Impact factor: 3.765

6.  Enteric excretion of baicalein, a flavone of Scutellariae Radix, via glucuronidation in rat: involvement of multidrug resistance-associated protein 2.

Authors:  Teruaki Akao; Yoko Sakashita; Masato Hanada; Hirozo Goto; Yutaka Shimada; Katsutoshi Terasawa
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

7.  Absorption and enterohepatic circulation of baicalin in rats.

Authors:  Jie Xing; Xiaoyan Chen; Dafang Zhong
Journal:  Life Sci       Date:  2005-08-16       Impact factor: 5.037

8.  Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.

Authors:  Li Zhang; Junjie Zhang; Liya Wang; Huiyun Xia
Journal:  Curr Eye Res       Date:  2009-04       Impact factor: 2.424

9.  The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin.

Authors:  C C Lin; D E Shieh
Journal:  Am J Chin Med       Date:  1996       Impact factor: 4.667

10.  Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells.

Authors:  Z Gao; K Huang; H Xu
Journal:  Pharmacol Res       Date:  2001-02       Impact factor: 10.334

View more
  1 in total

1.  The distribution and expression of claudin-5 and occludin at the rat blood-optic nerve barrier after borneol treatment.

Authors:  Di Jin; Feng Wang; Lijun Qu; Zhituo Li; Lianhong Jin; Ping Liu; Xiaolin Xu; Hao Cui
Journal:  Mol Biol Rep       Date:  2010-05-16       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.